long-term antibiotics for the draining ear

Van Niel, Cornelius W.
November 2007
Archives of Disease in Childhood;Nov2007, Vol. 92 Issue 11, p1043
Academic Journal
The article presents a case study about long-term antibiotics for draining ear among children. It is noted that otorrhea prevailed in fewer children who received trimethoprim/sulfamethoxazole (TMP/SMX) rather than placebo for six weeks. Studies show that topical antibiotic/corticosteroid ear drops are more effective than short-term oral antibiotics for acute and chronic otorrhea. It is suggested that long-term TMP/SMX is worth trying in children with chronically draining ears that do not respond to short-term therapy before referring them to otolaryngology. The interval complete blood counts should also be considered, despite of the minimal adverse effects with high TMP/SMX dose.


Related Articles

  • TMP/SMX FOR ACUTE MAXILLARY SINUSITIS. Smith, Gregory N.; Merenstein, Joel H. // Journal of Family Practice;Sep1995, Vol. 41 Issue 3, p294 

    This article discusses research being done on the effectiveness of trimethoprim/sulfamethoxazole in the treatment of acute maxillary sinusitis, with reference to a study by J. W. Williams, D. R. Holleman, G. P. Samsa and D. Simel, which appeared in the April 5, 1995 issue of the "Journal of the...

  • Ciprofloxacin vs co-trimoxazole for acute pyelonephritis.  // Caribbean Health;Oct2000, Vol. 3 Issue 3, p24 

    The article offers information on the standard treatment for acute pyelonephritis of women in the U.S. There were 255 adult premenopausal women randomised to oral ciprofloxacin 500 milligram twice daily for seven days or trimethoprim/sulphamethoxazole (T/S) 160/800 milligram twice daily for 14...

  • Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: a repeated cross-sectional study in Vellore, south India. Chandy, Sujith J.; Thomas, Kurien; Mathai, Elizabeth; Antonisamy, Belavendra; Holloway, Kathleen A.; Stalsby Lundborg, Cecilia // Journal of Antimicrobial Chemotherapy (JAC);Jan2013, Vol. 68 Issue 1, p229 

    Objectives There is considerable evidence linking antibiotic usage to bacterial resistance. Intervention strategies are needed to contain antibiotic use and thereby resistance. To plan appropriate strategies, it is imperative to undertake surveillance in the community to monitor antibiotic...

  • Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Wharton, J. Marcus; Coleman, Diana Lewis; Wofsy, Constance B.; Luce, John M.; Blumenfeld, Walter; Hadley, W. Keith; Ingram-Drake, Leslie; Volberding, Paul A.; Hopewell, Philip C.; Wharton, J M; Coleman, D L; Wofsy, C B; Luce, J M; Blumenfeld, W; Hadley, W K; Ingram-Drake, L; Volberding, P A; Hopewell, P C // Annals of Internal Medicine;Jul86, Vol. 105 Issue 1, p37 

    Forty patients with the acquired immunodeficiency syndrome (AIDS) and their first episodes of Pneumocystis carinii pneumonia were assigned at random to receive either trimethoprim-sulfamethoxazole or pentamidine isethionate. The two groups did not differ significantly in the severity of...

  • Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Carr, Andrew; Tindall, Brent; Brew, Bruce J.; Marriott, Deborah J.; Harkness, John L.; Penny, Ronald; Cooper, David A.; Carr, A; Tindall, B; Brew, B J; Marriott, D J; Harkness, J L; Penny, R; Cooper, D A // Annals of Internal Medicine;7/15/92, Vol. 117 Issue 2, p106 

    Objective: To determine the efficacy of low-dose trimethoprim-sulfamethoxazole (trimethoprim, 160 mg plus sulfamethoxazole, 800 mg; one tablet twice daily, 2 days per week) as primary prophylaxis against toxoplasmic encephalitis in patients with human immunodeficiency virus (HIV)...

  • Resistance to Trimethoprim-Sulfamethoxazole. Huovinen, Pentti // Clinical Infectious Diseases;6/1/2001, Vol. 32 Issue 11, p1608 

    Discusses the use of trimethoprim (TMP)-sulfamethoxazole as treatment and prophylaxis of patients with urinary tract infections. Mechanisms of bacterial resistance; Use of TMP and sulfonamides.

  • Reducing case fatality in HIV-infected TB patients in sub-Saharan Africa. Harries, A. D. // Southern African Journal of Epidemiology & Infection;2009, Vol. 24 Issue 3, p1 

    HIV-infected patients with tuberculosis (TB) have much higher case fatality rates compared with non-HIV-infected patients. There are various reasons for this high mortality that include delayed presentation and advanced TB at the time of diagnosis, incorrect diagnosis of smearnegative TB and...

  • TRIMETHOPRIM-SUI.FAMETHOXAZOLE-INDUCED VANISHING BILE DUCT SYNDROME. Yao, Francis; Behling, Cynthia A.; Saab, Sammy; Shujun Li; Hart, Marquis; Lyche, Kip D. // American Journal of Gastroenterology;Jan1997, Vol. 92 Issue 1, p167 

    Presents a case report of vanishing bile duct syndrome caused by trimethoprim-sulfamethoxazole (TMP-SMN) leading to progressive liver failure and liver transplantation. Medical history; Result of laboratory tests on the patient; Etiologies of the vanishing bile duct syndrome.

  • Asymptomatic proteinuria in a child with recurrent urinary tract infections-questions. Bayram, Meral; Alaygut, Demet; Öztürk, Yeşim; Sarıoğlu, Sülen; Soylu, Alper; Türkmen, Mehmet; Kavukçu, Salih // Pediatric Nephrology;May2012, Vol. 27 Issue 5, p761 

    A quiz on asymptomatic proteinuria in a child with recurrent urinary tract infections is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics